Who owns G1 Therapeutics?
- Ticker: GTHX
- CUSIP Number: 3621lq109
Tip: Access positions for across all investors
Analyze quarterly positions in G1 Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of G1 Therapeutics stock
Who bought or sold G1 Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 2.1M | $9.0M | 5% | Mar 2024 |
|
| Susquehanna International | 1.1M | $4.9M | 277% | Mar 2024 |
|
| Raymond James & Associates | 803k | $3.5M | 42% | Mar 2024 |
|
| D. E. Shaw & Co | 785k | $3.4M | 58% | Mar 2024 |
|
| BlackRock | 672k | $2.9M | -40% | Mar 2024 |
|
| Geode Capital Management | 506k | $2.2M | 15% | Mar 2024 |
|
| Goldman Sachs Group | 448k | $1.9M | 3808% | Mar 2024 |
|
| Millennium Management | 446k | $1.9M | 1336% | Mar 2024 |
|
| Acadian Asset Management | 434k | $1.9M | 230% | Mar 2024 |
|
| Standard Life Aberdeen | 424k | $1.8M | 0% | Mar 2024 |
|
| Connor, Clark & Lunn Investment Management | 414k | $1.8M | 115% | Mar 2024 |
|
| HAP Trading | 400k | $100k | 100% | Mar 2024 |
|
| Bank of America Corporation | 379k | $1.6M | 36% | Mar 2024 |
|
| Jacobs Levy Equity Management | 378k | $1.6M | 21% | Mar 2024 |
|
| Caption Management | 367k | $1.6M | 100% | Mar 2024 |
|
| Two Sigma Investments | 334k | $1.4M | 106% | Mar 2024 |
|
| Jane Street | 334k | $1.4M | 50% | Mar 2024 |
|
| Qube Research & Technologies | 325k | $1.4M | 100% | Mar 2024 |
|
| Man Group | 275k | $1.2M | 88% | Mar 2024 |
|
| Group One Trading | 229k | $989k | 389% | Mar 2024 |
|
| Bridgeway Capital Management | 191k | $826k | 37% | Mar 2024 |
|
| Two Sigma Advisers | 184k | $794k | 38% | Mar 2024 |
|
| Level Four Advisory Services | 179k | $545k | 0% | Mar 2024 |
|
| Cubist Systematic Strategies | 176k | $759k | 720% | Mar 2024 |
|
| Morgan Stanley | 175k | $758k | 399% | Mar 2024 |
|
| Hrt Financial | 141k | $608k | 100% | Mar 2024 |
|
| Citigroup | 129k | $558k | 50% | Mar 2024 |
|
| Northern Trust | 126k | $542k | 26% | Mar 2024 |
|
| Citadel Advisors | 120k | $518k | -10% | Mar 2024 |
|
| Squarepoint Ops | 105k | $454k | 548% | Mar 2024 |
|
| FinTrust Capital Advisors | 101k | $435k | 154946% | Mar 2024 |
|
| Denali Advisors | 86k | $372k | -29% | Mar 2024 |
|
| Franklin Street Advisors | 83k | $360k | 0% | Mar 2024 |
|
| Dimensional Fund Advisors | 78k | $335k | 1% | Mar 2024 |
|
| Curi Wealth Management | 71k | $216k | 0% | Dec 2023 |
|
| FMR | 60k | $259k | 492% | Mar 2024 |
|
| Jpmorgan Chase & Co | 55k | $236k | 21754% | Mar 2024 |
|
| Brevan Howard Capital Management | 48k | $205k | 100% | Mar 2024 |
|
| Beacon Pointe Advisors | 44k | $133k | 2% | Dec 2023 |
|
| Creative Financial Designs | 41k | $175k | 15% | Mar 2024 |
|
| Algert Coldiron Investors | 39k | $117k | -44% | Dec 2023 |
|
| Ameriprise Financial | 36k | $153k | -7% | Mar 2024 |
|
| Envestnet Asset Management | 35k | $153k | 45% | Mar 2024 |
|
| Rsm Us Wealth Management | 35k | $152k | 0% | Mar 2024 |
|
| American Century Companies | 35k | $150k | 100% | Mar 2024 |
|
| Jump Financial | 34k | $105k | 100% | Dec 2023 |
|
| Raymond James Financial Services Advisors | 31k | $136k | -7% | Mar 2024 |
|
| Wells Fargo & Company | 31k | $134k | 38% | Mar 2024 |
|
| Capstone Investment Advisors | 27k | $118k | 9% | Mar 2024 |
|
| Y-Intercept | 27k | $115k | 100% | Mar 2024 |
|
| PDT Partners | 22k | $97k | 100% | Mar 2024 |
|
| Charles Schwab Investment Management | 22k | $93k | 0% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 20k | $87k | -94% | Mar 2024 |
|
| ExodusPoint Capital Management | 20k | $85k | 100% | Mar 2024 |
|
| Graham Capital Management | 19k | $83k | 100% | Mar 2024 |
|
| T. Rowe Price Associates | 18k | $77k | 0% | Mar 2024 |
|
| Cambridge Investment Research Advisors | 17k | $73k | 42% | Mar 2024 |
|
| Leucadia National Corporation | 16k | $70k | 100% | Mar 2024 |
|
| Balyasny Asset Management | 16k | $68k | 100% | Mar 2024 |
|
| Point72 Asia | 15k | $65k | 100% | Mar 2024 |
|
| Oxford Asset Management | 15k | $64k | 100% | Mar 2024 |
|
| Financial Advocates Investment Management | 15k | $62k | 12% | Mar 2024 |
|
| LMR Partners | 14k | $61k | 100% | Mar 2024 |
|
| SG Americas Securities | 14k | $58k | 100% | Mar 2024 |
|
| CTC Alternative Strategies | 12k | $52k | 100% | Mar 2024 |
|
| Cutler | 12k | $1.0k | 100% | Mar 2024 |
|
| GSA Capital Partners | 11k | $47k | -59% | Mar 2024 |
|
| Advisor Group Holdings | 10k | $45k | -53% | Mar 2024 |
|
| XTX Topco | 10k | $45k | -97% | Mar 2024 |
|
| Quantbot Technologies | 8.8k | $38k | 29% | Mar 2024 |
|
| Barclays | 6.3k | $27k | 0% | Mar 2024 |
|
| Tower Research Capital | 4.1k | $18k | -49% | Mar 2024 |
|
| CWM | 1.5k | $6.0k | 0% | Mar 2024 |
|
| Federated Investors | 1.4k | $4.3k | -57% | Dec 2023 |
|
| Rhumbline Advisers | 967.00 | $4.2k | 0% | Mar 2024 |
|
| Hanson McClain Advisors | 750.00 | $3.2k | 0% | Mar 2024 |
|
| Proequities | 517.00 | $2.2M | 0% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 308.00 | $1.3k | 0% | Mar 2024 |
|
| UBS Group | 308.00 | $1.3k | -90% | Mar 2024 |
|
| Providence Capital Advisors | 212.00 | $916.009600 | 0% | Mar 2024 |
|
| Goss Wealth Management | 200.00 | $864.000000 | 0% | Mar 2024 |
|
| Royal Bank of Canada | 24.00 | $0 | -73% | Mar 2024 |
|
Who sold out of G1 Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Marshall Wace | Dec 2023 | 360k | $1.1M |
| Simplex Trading | Dec 2023 | 234k | $712k |
| 683 Capital Management | Dec 2023 | 64k | $195k |
| Virtu Financial | Dec 2023 | 45k | $136k |
| Bank of New York Mellon | Dec 2023 | 18k | $54k |
| Engineers Gate Manager | Sep 2023 | 14k | $21k |
| Two Sigma Securities | Dec 2023 | 14k | $43k |
| Ables, Iannone, Moore & Associates | Dec 2023 | 4.7k | $14k |
| Northwestern Mutual Wealth Management Company | Sep 2023 | 1.0k | $1.4k |
| Signature | Dec 2023 | 910.00 | $2.8k |
| Advisory Services Network | Dec 2023 | 500.00 | $1.5k |
| ICA Group Wealth Management | Dec 2023 | 50.00 | $153.000000 |